Effectiveness of Informational and Educational Tools to Improve the Experience of Relatives of ICU Patients. RELIEF, a Platform Trial
NCT ID: NCT06851884
Last Updated: 2025-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
562 participants
INTERVENTIONAL
2025-03-01
2027-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this research is to propose a variety of informational and educational tools to improve relatives' understanding of both the ICU context and the information provided, with the goal of reducing the risk of developing PTSD in the months following the patient's discharge or death.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liberalization of Visiting Policies in ICU for Reducing High Risk of Post-traumatic Stress Disorder
NCT03846323
Targeted Group-based Psychotherapy to Address Emotional Stress in at Risk ICU Survivors
NCT05856240
The Post Intensive Care Syndrome Follow-up and Management Study: the ICU Recovery Answers Project
NCT06504979
Evaluation of PTSD Family Coach, a Mobile Phone App for Family Members of Individuals With PTSD
NCT02486705
Short-Term Recall and Reprocess Therapy for Post Traumatic Stress Disorder (PTSD)
NCT06826937
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
The trials integrated into the platform trial are randomized and may be either conventional trials or adaptive MAMS (Multi-Arms Multi-Stage) trials. These involve multiple arms and phases, allowing for the adaptive evaluation of several interventions, with the possibility of adding or removing interventions during the trial.
Additionally, the trials include a hybrid control arm that combines randomized concurrent controls and historical external controls from an observational cohort.
Trial 1 : randomization according to a 1:2:2:2 ratio into one of the 4 arms:
* Control
* Video capsules
* Comic strips
* Virtual reality
Trial 2 : randomization according to a 1:2 ratio into the control or intervention arm (set of "end-of-life and grief" informational and educational tools, including a video capsule, a cartoon, and a kit of 2 leaflets).
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trial 1 : Control
Standard care with universal welcome leaflet. The control group is a hybrid, also including historical external controls from the cohort "Syndrome de Stress Post-traumatique chez les Proches de Patients Admitted to the Intensive Care Unit: A Multicentric, Observational, Prospective Study" according to the center's usual practice
Standard of Care (SOC)
Universal welcome leaflet on patient admission
Trial 1 : Video Capsule arm
Video capsules
3 video capsules of 3 minutes each
Trial 1 : Cartoon arm
Cartoon
3 cartoons
Trial 1 : Virtual reality arm
Virtual reality
3 virtual reality programs
Trial 2 : Control
Standard care with universal welcome leaflet. The control group is a hybrid, also including historical external controls from the cohort "Syndrome de Stress Post-traumatique chez les Proches de Patients Admitted to the Intensive Care Unit: A Multicentric, Observational, Prospective Study" according to the center's usual practice
Standard of Care (SOC)
Universal welcome leaflet on patient admission
Trial 2 : set of "end-of-life and grief" informational and educational tools
Set of "end-of-life and grief" informational and educational tools
Including a video capsule, a cartoon, and a kit of two leaflets
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of Care (SOC)
Universal welcome leaflet on patient admission
Video capsules
3 video capsules of 3 minutes each
Cartoon
3 cartoons
Virtual reality
3 virtual reality programs
Set of "end-of-life and grief" informational and educational tools
Including a video capsule, a cartoon, and a kit of two leaflets
Standard of Care (SOC)
Universal welcome leaflet on patient admission
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Relatives of patients with the following characteristics: ≥18 years old, treated in intensive care with invasive mechanical ventilation for at least 48 hours having received a visit from at least one relative within the first 72 hours.
* ≥18 years old
* Identified, if possible, by the patient as the reference person or person to be informed, or, if the patient is unable to communicate, identified by the healthcare providers as the "patient's reference relative."
* Understanding and speaking French • Having provided their phone contact information Only one relative of the patient is included in the study.
Trial 2 :
Relatives of patients with the following characteristics: ≥18 years old, having been treated in intensive care with invasive mechanical ventilation for at least 48 hours, for whom a decision of withhold or withdraw treatment has been made with expected death in intensive care.
* ≥18 years old
* Identified, if possible, by the patient as the reference person or person to be informed, or, if the patient is unable to communicate, identified by healthcare providers as the "patient's reference relative."
* Present at the end-of-life conference (announcement of the EOL decision)
* Understanding and speaking French
* Having provided their phone contact information
Only one relative of the patient is included in the study. They are included just before or just after the end-of-life conference.
Exclusion Criteria
* Planned or considered organ donation
* Detained or deprived of liberty
* Under guardianship or curatorship
* No social security
Relatives :
* Social context making follow-up and telephone interviews difficult (homeless individuals, not residing in Europe or the overseas territories)
* Inability to provide a "stable" personal mobile number (temporary phone number or not in their own name or the name of their spouse/partner)
* Under guardianship or curatorship
* Inability to communicate by phone (hearing impairments, etc.)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP240666
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.